Ecosystem
Beta Site
Search Results
13 items found for "Sonja Peter"
- [1,2,4]Triazolo[1,5-c]pyrimidines as Tools to Investigate A3 Adenosine Receptors in Cancer Cell Lines
Biasinutto , Giovanni Bolcato , Veronica Salmaso , Tatiana Da Ros , Teresa Gianferrara , Filippo Prencipe , Sonja
- Ep 57 with Dr. Peter Robert Banks
Peter Robert Banks About Dr. Peter Robert Banks Peter Banks is currently the Scientific Director at BioTek Instruments , now a part Peter Robert Banks on the web LinkedIn Dr.
- Structure-based discovery of functionally selective 5-HT1A receptor agonists
selective 5-HT1A receptor agonists Date & Time Saturday, November 4th / 9:05 AM Abstract Coming Soon About Peter Peter Gmeiner received his Ph.D. from the University of Munich. Peter has been chaired Full Professor of Pharmaceutical / Medicinal Chemistry at the Friedrich-Alexander Peter Gmeiner has been spokesman of the Research Training Group "Medicinal Chemistry of Selective GPCR Ligands" (GRK 1910). " Peter Gmeiner on the web Friedrich Alexander University Erlangen-Nürnberg Pubmed
- Ep 88 with Dr. Hannes Schihada
By the end of 2021, I moved back to Germany and joined the pharmaceutical chemistry group of Peter Kolb
- Aberrant hormone receptors regulate a wide spectrum of endocrine tumors
Authors André Lacroix, Isabelle Bourdeau, Fanny Chasseloup, Peter Kamenický, Antoine-Guy Lopez, Estelle
- Pancreatic ductal adenocarcinoma, β-blockers and antihistamines: A clinical trial is needed
Authors Jillian G Baker, Erica K Sloan, Kevin Pfleger, Peter J McCormick, Cristina Salmerón, Paul A Insel
- Purinergic GPCR-integrin interactions drive pancreatic cancer cell invasion
Carter , Nicolas Jaime Roth , Jessica Gibson , Ariana Samadi , Hemant M Kocher , Sabrina Simoncelli , Peter
- NPFF stimulates human ovarian cancer cell invasion by upregulating MMP-9 via ERK1/2 signaling
Authors Ze Wu , Qiongqiong Jia , Boqun Liu , Lanlan Fang , Peter C K Leung , Jung-Chien Cheng Tags Invasion
- Spliceosome mutations are associated with clinical response in a phase 1b/2 study of the PLK1 inhibitor onvansertib in combination with decitabine in relapsed or refractory acute myeloid leukemia
Authors Peter J P Croucher , Maya Ridinger , Pamela S Becker , Tara L Lin , Sandra L Silberman , Eunice
- Session V | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Seufert2, Yin Kwan Chung3, Daniela Volke1, Ralf Hoffmann1, Torsten Schöneberg4, Tobias Langenhan3, Peter Chung, Yin Kwan2, Pohl, Fabian2, Batebi, Hossein1 Sträter, Norbert3 , Langenhan, Tobias2 & Hildebrand, Peter
- Neuroimmune interplay during type 2 inflammation: symptoms, mechanisms and therapeutic targets in atopic diseases
Marc E Rothenberg , Xin Sun , Claus Bachert , David Artis , Raza Zaheer , Yamo Deniz , Paul Rowe , Sonya
- Student Flash Presentations | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
& Affiliations "Srivastava, Swati1; Singh, Abhishek Kumar1; Gunawan, Felix2; Gentile, Alessandra2; Petersen Authors & Affiliations "Brodmerkel Lara-Sophie 1, Bormann Anne 1, Seufert Florian 2, Hildebrand Peter Berlin, Germany ´ correspondence: scholzlab@gmail.com , Dmitrij.Ljaschenko@medizin.uni-leipzig.de , peter.hildebrand
- Ep 104 with Dr. Raul Gainetdinov
Gainetdinov is the Institute of Translational Biomedicine Director at Saint Petersburg State University Raul Gainetdinov on the web Saint-Petersburg State University Wikipedia Google Scholar Researchgate Google
